Coherus Oncology, Inc. Operating Lease Right-of-Use Assets
Coherus Oncology, Inc. (CHRS) had Operating Lease Right-of-Use Assets of $2.95 million as of 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-03-09
- 2025-12-31: Operating Lease, Right-of-Use Asset $2.95M.
- 2024-12-31: Operating Lease, Right-of-Use Asset $4.52M.
- 2023-12-31: Operating Lease, Right-of-Use Asset $5.91M.
- 2022-12-31: Operating Lease, Right-of-Use Asset $5.69M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2025-12-31 | $2.95M 10-K · filed 2026-03-09 |
| 2024-12-31 | $4.52M 10-K · filed 2026-03-09 |
| 2023-12-31 | $5.91M 8-K · filed 2025-11-13 |
| 2022-12-31 | $5.69M 10-K · filed 2024-03-15 |
| 2021-12-31 | $8.19M 10-K · filed 2023-03-06 |
| 2021-06-30 | $8.90M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $9.43M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $9.96M 10-K · filed 2022-02-23 |
| 2020-09-30 | $10.47M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $11.00M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $11.53M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $10.65M 10-K · filed 2021-02-25 |
| 2019-09-30 | $11.13M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $6.35M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $6.77M 10-Q · filed 2019-05-09 |
| 2019-01-01 | $7.20M 10-K · filed 2020-02-27 |
| 2018-12-31 | $0.00 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |